Award

Renewal of the Wellcome Trust Centre for Cell-Matrix Research

Description: Dysregulation of matrix is a central process in the pathogenesis of major human chronic diseases affecting the cardiovascular system, the kidney, and musculoskeletal tissues, and is a feature of multisystem cancers. Matrix dysregulation is also a critical factor in fibrosis (scarring). The Centre’s philosophy is that cell-matrix interactions are pivotal in health and disease. Using new insight gained through the Centre’s recent major discoveries, our research will focus on the regulation of matrix formation in health and dysregulation in disease. To achieve our goals the research programme is based on three themes: ChronoMatrix, ImmunoMatrix, and MechanoMatrix, and arising from them, an initiative in Fibrosis. In these we will investigate how peripheral circadian clocks, tissue mechanics and immune surveillance direct cells to modify their matrix and are in turn controlled by matrix. This provides a framework for determining the fundamental mechanisms underpinning matrix assembly, disassembly and renewal and the pathways that lead to damage and disruption, or to excessive matrix, that compromises function. The renewal of the Centre, together with the momentum of our research advances, will enable this programme to deliver a step-up in our understanding of, and the identification of therapeutic strategies to combat, cell-matrix dysfunction in disease.
Amount: £4,976,000
Funding type: grant
Funder scheme: Wellcome Trust Centres - New Call
Start date: 2016-12-01
End date: 2021-11-30
Subfield: Cell Biology
Funded outputs count: 162
Funder award ID: 203128/Z/16/Z
OpenAlex ID: G2587533398
2026 · Suruchi Poddar, Dorothea A. Erxleben, et al. · Proceedings of the National Academy of Sciences · 1
2026 · Huw F. Purssell, Stephanie R. Landi, et al. · Hepatology Communications
2026 · William H. Zammit, Lucy J. Le Maistre, et al. · Cell Reports · 2
2026 · Milan Collins, Lorna Young, et al. · bioRxiv (Cold Spring Harbor Laboratory)
2026 · Gareth Moore, Raluca Revici, et al. · Development · 3
2025 · J. E. Parkinson, G. E. Baldwin, et al. · Transgenic Research · 1
2025 · James E. Parkinson, Hannah E. Tompkins, et al. · Science Immunology · 5
2025 · Matthew Jones, Hannah Percival, et al. · Scientific Reports · 6
2025 · Robert Pedley, Charlotte E. L. Mellor, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
2025 · Luciana Renata de Oliveira, Matheus Gimenez Fernandes, et al. · Frontiers in Molecular Biosciences · 1
2025 · Nigel L Hammond, Syed Murtuza Baker, et al. · EMBO Molecular Medicine · 16
2025 · Chara E. S. Spanou, Chengeng Yang, et al. · The FASEB Journal · 7
2024 · Rebecca J. Dodd, Judith E. Allen, et al. · mBio · 7
2024 · Rebecca J. Dodd, Dora Moffatt, et al. · Proteoglycan Research · 7
2024 · Rebecca J. Dodd, Charles D. Blundell, et al. · Journal of Biological Chemistry · 14
2024 · Maria Antonia Llopis-Grimalt, Marta Munar-Bestard, et al. · ACS Omega · 7
2024 · Tomas Malinauskas, Gareth Moore, et al. · Nature Communications · 18
2024 · Judith B. Fülle, Rogerio Alves de Almeida, et al. · Molecular & Cellular Proteomics · 13
2024 · Christine Chew, Oliver J Brand, et al. · Matrix Biology · 18